
OBLN
Healthcare · Medical Devices · $30.6M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2021
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 12, 2021 | Time not confirmed | — | -1.32 | — |
| Mar 12, 2021 | After the close | -0.06 | -0.17 | -183.3% |
| Nov 6, 2020 | After the close | -0.07 | -0.20 | -185.7% |
| Jul 30, 2020 | Before the open | -0.30 | -0.54 | -80.0% |
| Jun 19, 2020 | Before the open | -0.51 | -0.68 | -33.3% |
| Feb 27, 2020 | After the close | -0.55 | -0.64 | -16.4% |
| Nov 8, 2019 | After the close | -5.70 | -6.10 | -7.0% |
| Jul 24, 2019 | After the close | -1.95 | -2.50 | -28.2% |
| May 10, 2019 | After the close | -3.33 | -3.60 | -8.3% |
| Feb 22, 2019 | After the close | -3.22 | -3.90 | -21.1% |
| Nov 2, 2018 | After the close | -4.62 | -3.50 | +24.2% |
| Aug 2, 2018 | After the close | -4.93 | -5.70 | -15.5% |
| May 10, 2018 | After the close | -5.03 |
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation…
| -7.10 |
| -41.3% |
| Mar 5, 2018 | After the close | -4.55 | -6.00 | -31.9% |